Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Daré Bioscience ( (DARE) ) has shared an update.
On April 16, 2026, Daré Bioscience rebalanced its classified board by reclassifying director Gregory W. Matz from Class II, with a term previously expiring at the 2028 annual meeting, to Class III, with a term now expiring at the 2026 annual meeting. Matz formally resigned as a Class II director and was simultaneously reappointed as a Class III director, preserving the staggered board structure while keeping his board service and committee assignments otherwise uninterrupted.
As a result of the change, Matz will stand for re-election at the 2026 annual meeting of stockholders alongside Sabrina Martucci Johnson, the company’s other Class III director. The move was undertaken solely to ensure that each of the three director classes consists, as nearly as possible, of one-third of the total six-member board, with no impact on Matz’s ongoing responsibilities or continuity of service.
The most recent analyst rating on (DARE) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Daré Bioscience stock, see the DARE Stock Forecast page.
Spark’s Take on DARE Stock
According to Spark, TipRanks’ AI Analyst, DARE is a Neutral.
The score is held down primarily by weak financial performance (large losses, significant 2025 cash burn, and historical balance-sheet instability). Offsetting this are moderately positive technical momentum indicators and a constructive earnings narrative around upcoming product launches and grant-supported pipeline progress, though recent financings and capital-raising constraints keep risk elevated.
To see Spark’s full report on DARE stock, click here.
More about Daré Bioscience
Daré Bioscience, Inc. is a biopharmaceutical company operating in the life sciences industry. It is governed by a classified board structure, with directors divided into three classes serving staggered three-year terms, a common corporate governance model among public companies seeking board continuity and stability.
Average Trading Volume: 84,907
Technical Sentiment Signal: Hold
Current Market Cap: $26.06M
For detailed information about DARE stock, go to TipRanks’ Stock Analysis page.